ReviewFrontiers in endocrinology2026
Artificial intelligence in thyroid ultrasound: clinical applications and perspectives.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid nodules are highly prevalent, with increasing detection rates driven by advanced imaging and expanded screening. Ultrasound serves as the first-line tool for screening, diagnosis and follow-up, owing to its non-invasiveness, real-time capability, cost-effectiveness and absence of ionizing radiation. However, conventional ultrasound diagnosis is highly operator-dependent, resulting in substantial inter-observer variability and diagnostic errors, particularly for subtle or indeterminate lesions. Artificial intelligence (AI), particularly deep learning and radiomics, has emerged as a promising approach to address these limitations by enabling automated feature extraction, quantitative analysis and standardized interpretation, which has the potential to improve diagnostic efficiency and risk stratification. This review summarizes AI applications in thyroid ultrasound, including image preprocessing, nodule segmentation, quantitative feature analysis, benign-malignant differentiation, TIRADS optimization and automated reporting. We highlight AI's potential in enhancing diagnostic consistency and accuracy, while critically assessing the methodological quality, bias risks and external validation of existing studies. Most AI tools are still in early translational phases, lacking large-scale validation in real clinical settings and standardized reporting protocols. We further discuss key challenges, including data bias, limited generalizability due to small or single-center datasets, poor interpretability and significant translational barriers. Future directions involving multi-modal fusion, explainable AI, real-time clinical systems and rigorous, multi-center standardized validation are proposed to facilitate clinical translation and improve patient care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.